PARP1 and Crohn disease: Crohn's disease: STC1 upregulation → binds to PARP1 → activates the JNK pathway → promotes oxidative stress‐related cell death and inflammation. Intervention: STC1 knockout or PARP1/JNK inhibition alleviates colitis.